COMMUNIQUÉS West-GlobeNewswire

Golden Leaf Holdings Ltd. Announces Election of New Board of Directors, Approval of Amendment to Terms of Debenture Indenture for Debentures Maturing November 2, 2019 and Release of Slide Presentation
26/06/2019
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” of the “Company”), a cannabis company with cultivation, production and retail operations built around [...]
Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering
26/06/2019
SOUTH SAN FRANCISCO, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative [...]
Driven Deliveries Inc. Announces Partnership with Cypress Hill Rapper, B-Real’s, Dr. Greenthumb’s Dispensary
26/06/2019
SAN DIEGO, June 26, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc. (DRVD), the world’s first publicly traded cannabis delivery company, announced today that they have partnered with Dr. Greenthumb’s Dispensary to [...]
Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo® (nivolumab) Phase 1 Combination Trial in Brain Cancer
26/06/2019
– Enrollment completed in third cohort of dose-escalation study at leading brain cancer hospitals in US; Investigators indicate interest in expanding study – BOSTON, June 26, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology [...]
Letter to Shareholders from Curt Fairbrother, CEO
26/06/2019
CORONA, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- Dear Shareholders: The filing delay for our 10K and 10Q will be coming to an end shortly. I wanted to take this opportunity first to assure you that the reason for the [...]
CorMedix Inc. Set to Join the Russell 2000® Index
26/06/2019
BERKELEY HEIGHTS, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
XBiotech Wins “Commercial Real Estate Award for Industrial Development” for its Headquarters in Austin, Texas
26/06/2019
AUSTIN, Texas, June 26, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that it is the recipient of the first place 2019 Commercial Real Estate Award for Industrial Development, chosen by the [...]
Acasti Pharma Provides Fiscal 2019 Year-End Business Update
26/06/2019
Both Phase 3 TRILOGY studies at 100% randomization >60% of patients have completed the 6-month trial Release of topline results remain on track Fully funded beyond completion of Phase 3 studies Conference call to be [...]
Aptinyx Presents Preclinical Data Demonstrating Robust Activity of NYX-783 on Alcohol-Seeking Behavior and Relapse-Like Behavior in Multiple Models of Alcohol Use Disorder
26/06/2019
EVANSTON, Ill., June 26, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Cambrex Strengthens Leadership Team to Support Integrated Small Molecule End-to-End Service Offering
26/06/2019
EAST RUTHERFORD, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Trial
26/06/2019
Gemcabene safely lowered serum triglycerides (TGs), the primary endpoint, in a subset of FPLD patients LIVONIA, Mich., June 26, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP) today announced top-line [...]
BioSyent Announces Withdrawal of Health Canada Submissions for Cardiovascular Products
26/06/2019
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) announces that it has informed Health Canada that it will be withdrawing its New Drug Submissions for two cardiovascular products, [...]
Predictive Oncology Subsidiary, Helomics, Signs Collaborative Research Agreement with ChemImage to Expand Personalized Medicine to Prostate Cancer Prognosis and Treatment
26/06/2019
MINNEAPOLIS, Minn., June 26, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]
Daré Bioscience Completes Recruitment in Pre-Pivotal Trial Of Monthly Woman-Controlled, Hormone-Free Contraceptive Candidate, Ovaprene®
26/06/2019
Ovaprene has the Potential to be the First FDA-Approved Monthly, Self-Administered, Hormone-Free Contraceptive SAN DIEGO, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women [...]
US Patent Office Issues New Transplant Patent to CareDx
26/06/2019
CareDx continues to lead innovation in transplantation BRISBANE, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and [...]
Kaleido Biosciences to Highlight Chemistry-Driven Approach at Microbiome Movement – Drug Development Summit
26/06/2019
Members of leadership team to participate in sessions discussing the role of the microbiome in human disease Summit coincides with World Microbiome Day: June 27, 2019 LEXINGTON, Mass., June 26, 2019 (GLOBE NEWSWIRE) -- [...]
Abeona Therapeutics Appoints Dr. Victor Paulus Senior Vice President of Regulatory Affairs
26/06/2019
NEW YORK and CLEVELAND, June 26, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Victor Paulus, Ph.D. as Senior [...]
AZTherapies to Present at Maxim Group’s Conference on Alzheimer’s Disease
26/06/2019
Presentation to highlight Company’s late-stage clinical program and unique approach to neuroinflammation and the treatment of early Alzheimer’s disease BOSTON, June 26, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc. , a [...]
ProMIS Neurosciences Closing Private Placement
26/06/2019
NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on [...]

Pages